ALKBH5 and metabolic dysfunction-associated steatotic liver disease: In a mouse model of NAFLD, inhibiting ALKBH5 regulated hepatic autophagy flux, thereby alleviating hepatic steatosis and fibrosis (Meng et al., 2023).